Note: Not all species have been tested for usefulness with this product. Only those species listed have been tested. We cannot make any guarantees about additional reactivities which may or may not occur.
The antiserum was produced against synthesized non-phosphopeptide derived from human NFB-p65 around the phosphorylation site of serine 311 (F-K-SP-I-M).
Species Reactivity:
This antibody is reactive against Human, Mouse, Rat
Applications:
Uses:
This antibody is useful for:
Western Blot 1:500-1:1000
immunohistochemistry-Paraffin 1:50-1:100
Dilutions:
Immunohistochemistry-Paraffin, Western Blot 1:500-1:1000
Aliquot and store at -20 °C or -80 °C. Avoid freeze-thaw cycles.
Buffer:
phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, and 50% glycerol.
Preservative:
0.02% Sodium Azide
Limitations:
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Products are guaranteed for 6 months from date of receipt, except for peptides and proteins which are guaranteed for 3 months.
p65 is a subunit of the nuclear factor kappa B. The transcription factor NFkB is widely recognized as a critical mediator of immune and inflammatory responses. In most cell types, NFkB is found in the cytoplasm where it is associated with an inhibitory protein known as IkB. An impressive variety of stimuli (tumor necrosis factor, interleukin 1, T cell activation signals, bacterial endotoxins, viral transforming proteins, certain growth factors and reactive oxygen intermediates) lead to the rapid nuclear accumulation of NFkB by the induced phosphorylation and subsequent degradation of IkB. In the nucleus, NFkB regulates genes encoding cytokines, cytokine receptors, cell adhesion molecules, proteins involved in coagulation and genes involved in cell growth control. Additionally, NFkB is thought to be an important transcriptional regulator for HIV. Growing evidence indicates that the dysregulation of NFkB may be key to a number of diseases including arthritis and other inflammatory diseases, Alzheimer's disease, atherosclerosis and cancer.
Western Blot: NFkappaB-p65 Antibody [NB100-82081] - Western blot analysis of extracts from Hela cells untreated or treated with IFN, using NFêB-p65 (Ab-311) antibody (Lane 1 and 2) and NFêB-p65 (phospho-Ser311) antibody (Lane 3 and 4).
Immunohistochemistry: NFkappaB-p65 Antibody [NB100-82081] - Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue, using NFêB-p65 (Ab-311) antibody.